Conditions: Hypercholesterolemia Hypertension
Keywords: LDL Cholesterol
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 143
Healthy volunteers: no

Brief summary:
This Phase 2 study will assess the efficacy and safety of ETC-1002 monotherapy versus placebo in participants with hypercholesterolemia and hypertension.

Detailed description:

Arms:
arm 1: ETC-1002 180 mg/day arm 2: Placebo control

Interventions: intervention 1: ETC-1002 intervention 2: Placebo
Intervention descriptions: intervention 1: ETC-1002 capsules taken once daily intervention 2: Placebo capsules taken once daily

Protocol document: